Paul Tudor Jones’s Elevance Health ELV Stock Holding History

Paul Tudor Jones’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.37M	Sell	11,300 -10,300	-48%	-$3.82M	0.01%	1381
2026 Q1	$6.32M	Buy	21,600 +8,000	+59%	+$2.63M	0.01%	1032
2025 Q4	$4.77M	Sell	13,600 -42,500	-76%	-$14.4M	0.01%	1183
2025 Q3	$18.1M	Buy	56,100 +50,900	+979%	+$15.8M	0.03%	487
2025 Q2	$2.02M	Buy	5,200 +2,200	+73%	+$885K	﹤0.01%	1664
2025 Q1	$1.3M	Sell	3,000 -24,800	-89%	-$9.96M	﹤0.01%	1637
2024 Q4	$10.3M	Buy	27,800 +26,300	+1,753%	+$11M	0.04%	349
2024 Q3	$780K	Buy	1,500 +600	+67%	+$321K	﹤0.01%	1772
2024 Q2	$488K	Buy	+900	New	+$476K	﹤0.01%	1814
2024 Q1	–	Sell	-16,000	Closed	-$7.54M	–	2358
2023 Q4	$7.54M	Buy	16,000 +14,000	+700%	+$6.47M	0.06%	445
2023 Q3	$871K	Sell	2,000 -4,700	-70%	-$2.13M	0.01%	1372
2023 Q2	$2.98M	Buy	+6,700	New	+$3.09M	0.04%	685
2022 Q4	–	Sell	-2,200	Closed	-$998K	–	2502
2022 Q3	$998K	Buy	+2,200	New	+$1.05M	0.02%	911
2022 Q1	–	Sell	-1,500	Closed	-$694K	–	2182
2021 Q4	$694K	Sell	1,500 -1,300	-46%	-$547K	0.01%	1242
2021 Q3	$1.04M	Buy	+2,800	New	+$1.06M	0.02%	1129

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Paul Tudor Jones's ELV Position: Q2 2026 in Review

Paul Tudor Jones sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 25,499 shares — an estimated $9.46M sold.

Paul Tudor Jones first reported a position in ELV in Q2 2013 and held it in 37 quarters. The position peaked at $25.1M in Q3 2025. 1,596 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Paul Tudor Jones reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
Paul Tudor Jones sold 25,499 Elevance Health shares in Q2 2026, an estimated $9.46M.
Paul Tudor Jones first reported a position in Elevance Health in Q2 2013 and held it in 37 quarters.
Paul Tudor Jones's Elevance Health position peaked at $25.1M in Q3 2025.
1,596 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.